(Q52648797)

5 May 2018

title

Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links. (English)

1 reference

5 May 2018

0 references

1 reference

1 reference

1

1 reference

5 May 2018

Josep Dalmau

series ordinal

2

1 reference

5 May 2018

language of work or name

English

0 references

publication date

25 March 2014

1 reference

5 May 2018

published in

Molecular Psychiatry

1 reference

5 May 2018

volume

19

1 reference

5 May 2018

issue

10

1 reference

5 May 2018

page(s)

1054

1 reference

5 May 2018

https://scigraph.springernature.com/pub.10.1038/mp.2014.25

exact match

0 references

cites work

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2014.25

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2014.25

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2014.25

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2014.25

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MP.2014.25

1 reference

5 May 2018

1 reference

5 May 2018